PET/CT:
ACR (American College of Radiology) Accredited Facility
In July of 2000, Reno Diagnostic Centers introduced PET technology to Northern Nevada. By doing so, RDC added an important new dimension to a physician's ability to diagnose and manage cancer.
Unlike other imaging technologies that detect changes in the physical size or structure of internal organs, PET detects changes in cellular function. Since these functional changes may take place before physical changes occur, PET often provides an earlier diagnosis of diseases. If these diseases have already been detected by an imaging exam, such as CT or MRI study, PET can often characterize the cellular function early in the course of the disease.
These capabilities can, in turn, translate into faster initiation of the best treatment, often avoiding more invasive exams or exploratory surgery. A PET study can:
- Help diagnose a problem.
- Help your physician predict the likely outcome of various therapeutic alternatives.
- Help pinpoint the best approach for treatment.
- Monitor your progress so that if you're not responding as well as expected, you can be switched to a more effective therapy immediately.
Your physician will be able to tell you precisely what he/she hopes to learn from your PET exam. As far as risks are concerned, there are little or no risks. A PET study is similar to many other diagnostic procedures. The radiation is similar to receiving two x-rays.
How PET Works
When disease strikes, the biochemistry of your tissues and cells change. In cancer, for example, cells begin to grow at a much faster rate. A PET scan takes a digital picture of abnormal cellular structure.
The most common form of a PET scan begins with an injection of a glucose-based radiopharmaceutical (FDG), which travels through the body, eventually collecting in the organs and tissues targeted for examination. The patient lies flat on a bed/table that moves incrementally through the PET scanner. The scanner has cameras that detect the gamma rays emitted from the patient, and turns those into electrical signals, which are processed by a computer to generate the medical images. The bed/table moves a few inches again, and the process is repeated.
This produces the digital images, which are assembled by the computer into a 3-D image of the patient's body. If an area is cancerous, the signals will be stronger there than in surrounding tissue, since more of the radiopharmaceutical (FDG) will be absorbed in those areas.
Why PET Works
PET scans give information about the body's chemistry that is not available with other imaging techniques.
PET scans reveal metabolic information (as opposed to anatomical information), providing your physician with extra insight.
Because PET scanning often reveals disease much earlier than conventional diagnostic procedures (such as CT or MRI), it can help physicians diagnose disease faster.
What PET Sees
PET is a procedure that is able to detect small cancerous tumors, and also subtle changes in the brain and heart. This enables physicians to treat these diseases earlier and more accurately than if they waited for the results from other detection modalities.
A PET scan puts time on your side! The earlier the diagnosis, the better the chance for successful treatment.
PET scans offer patients hope.
- PET can detect disease sooner and the earlier the detection, the more likely the cure! Prior to changes in structure that normally would show up on a CT or MRI scan, a PET scan can reveal metabolic changes in the body. Cancer is a metabolic process and PET is a metabolic imaging technique.
- PET shows the extent of disease - called staging - of lung cancer, colorectal cancer, melanoma, head and neck cancer, breast cancer, lymphoma and many other cancers. For patients whose cancer is newly diagnosed, it is important to determine if the cancer has spread to other parts of the body so that appropriate treatment can be started. PET can search the entire body for cancer in a single examination with a "whole body scan," revealing the primary site (s) as well as any metastases.
- PET shows whether a tumor is benign or malignant. Reports in scientific literature find that, in some tumors, PET correctly identifies detected lesions 95% of the time. Painful, costly and invasive surgery, such as thoracotomy, may no longer be necessary for diagnosis.
- PET shows the effectiveness of therapy. It is an excellent way to monitor progress and test recurrence of disease. For example, an ovarian cancer patient with a blood test that indicated a rise in her tumor marker levels had a PET scan after both CT and MRI scans were still registering no cancer. Only the PET scan showed the new cancer. After treatment, a subsequent PET scan revealed that the cancer was gone.
Is PET Safe?
The risks associated with a PET scan are very minimal. The quantity of radiation is low and the FDG degrades quickly so that no detectable radioactivity is present after several hours. In addition to the radioactive decomposition, the remaining FDG is eliminated from the body through urine. Family members are not at risk for exposure since greater than 90% of the radioactivity has left the body or decomposed before the patient has left the center.
Is a PET scan painless?
The only pain involved is the needle prick when you receive the radiopharmaceutical injection which does not differ from any other type of injection.
How does a PET scan differ from CT or MRI scans?
CT and MRI scans are anatomic imaging modalities, which means they look at the size and shape of organs and body structures. A PET scan is a metabolic imaging modality, which means it looks at function. The information collected from a PET scan is different from any other test that is available.
|
Latest News
Benefit of mammograms even greater than thought
June 28th, 2011
June 28, 2011 -- CHICAGO (Reuters) - The longest-running breast cancer screening study ever conducted has shown that regular mammograms prevent deaths from breast cancer, and the number of lives saved increases over time, an international research team said on Tuesday...
Read More
Breast MRI makes DCIS surgical planning more accurate
May 4th, 2011
Using breast MRI before surgically treating ductal carcinoma in situ (DCIS) makes for more accurate staging, according to research presented Tuesday at the American Roentgen Ray Society (ARRS) annual meeting in Chicago...
Read More
|